ArticleLaryngoscope investigative otolaryngology2026
Obesity and New-Onset Asthma Risk in Chronic Rhinosinusitis: A Population-Based Cohort Study.
Article in Laryngoscope investigative otolaryngology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Obesity and chronic rhinosinusitis (CRS) are independently associated with asthma, yet their combined impact on asthma risk remains less understood. This study evaluates the association between elevated body mass index (BMI) and new-onset asthma and asthma exacerbations in patients with CRS. Methods: A retrospective cohort study was conducted using the TriNetX U.S. Collaborative Network. Adults ≥ 18 years with unspecified CRS and recorded BMI from 2009 to 2019 were identified. Patients with prior functional endoscopic sinus surgery were excluded. Cohorts were stratified by BMI (healthy, overweight, obese) and matched 1:1 by demographics and comorbidities. Primary outcomes were adjusted relative risks (aRR) of new-onset asthma and asthma exacerbations within 1, 2, and 5 years after BMI classification. A secondary analysis was performed in patients without CRS using the same BMI stratification and matching approach. Results: Overweight CRS patients had a higher risk of new-onset asthma (aRR = 1.13, 95% CI 1.10-1.17) and exacerbations (aRR = 1.24, 95% CI 1.18-1.30) at 1 year compared to healthy-weight controls, with similar trends at 2 and 5 years. Obese CRS patients showed greater risks of new-onset asthma (aRR = 1.44, 95% CI 1.40-1.48) and exacerbations (aRR = 1.71, 95% CI 1.63-1.79) at 1 year, persisting at 2 and 5 years. In secondary analyses, elevated BMI was associated with increased relative asthma risk in patients without CRS, though absolute rates remained higher among CRS patients. Conclusions: Elevated BMI is associated with increased risk of asthma onset and exacerbations in CRS patients, with a graded relationship across BMI categories. Secondary analyses in patients without CRS suggest this association likely reflects the broader relationship between excess adiposity and asthma rather than a uniquely CRS-specific effect; however, higher absolute asthma rates among CRS patients support the clinical relevance of BMI assessment in this population. Level of Evidence: 4.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.